Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Martek wins patent infringement suit

This article was originally published in The Tan Sheet

Executive Summary

A court in Dusseldorf, Germany, has made a verbal order in favor of DHA marketer Martek Biosciences in its European patent infringement lawsuit against Lonza, Celanese Ventures and Nutrinova Nutrition Specialties & Food Ingredients, Martek says Oct. 23. A three-judge panel ruled the defendants violated Martek's European DHA patent relating to microbial oils containing at least 35% DHA in functional foods and dietary supplements. A written order is expected within 30 days. The patent has been the subject of opposition proceedings in the EU since 1999, though a final resolution is expected in the second half of 2008. A U.S. federal district court in 2006 ruled Lonza's DHA activities infringed three U.S. Martek patents (1"The Tan Sheet" Oct. 30, 2006, p. 13)...

You may also be interested in...



Martek gains strength in patent lawsuit

Martek Biosciences announces Nov. 1 a judge in the U.S. District Court for the District of Delaware will enter a permanent injunction against Lonza, Ltd., Nutrinova Inc. and Nutrinova Nutrition Specialties & Food Ingredients GmbH in a patent infringement suit. In October, a court in Dusseldorf, Germany made a verbal order in favor of DHA marketer Martek Biosciences in its European patent infringement lawsuit against Lonza (1"The Tan Sheet" Oct. 29, 2007, In Brief). The suit involves Lonza's U.S. sale of fatty acid product Lonza DHA for use in functional foods and dietary supplements. The U.S. judge upheld the October 2006 jury verdict that Lonza infringed on Martek's three patents (2"The Tan Sheet" Oct. 30, 2006, p. 13). Columbia, Md.-based Martek says it expects Lonza to appeal the decision to the U.S. Court of Appeals for the Federal Circuit. "The permanent injunction will be in effect pending any appeal," the firm says...

Martek Expects Growth With Restructuring Plan, Including Layoffs

Martek Biosciences continues to push its growth with a new restructuring plan that should make it leaner and meaner, according to an Oct. 26 release

Cybersecurity: Guidance Docs To Come, But Legacy Devices Still A Challenge

Increasing savvy around cybersecurity issues is driving regulators and trade groups to update their approach to the area, speakers from the US FDA and the American Medical Association said at this week’s FDA/CMS Summit.

Topics

UsernamePublicRestriction

Register

PS101049

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel